PUBLICATIONS

MERMAID II - -
Nielsen A, Kjaer SK, Munk C, Iftner T Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sexual Transmitted Diseases 2008; 35:276-282
Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. International Journal of Cancer 2008 15; 123(8):1864-70
Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T; Joint European Cohort Study. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008 Oct 13;337:a1754.
Nielsen A, Iftner T, Munk C, Kjaer SK. Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sexual Transmitted Diseases 2009; 36(10):609-15
Nielsen A, Kjaer SK, Munk C, Osler M, Iftner T. Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women. Journal of Medical Virology 2010 ; 82(4):616-23
Kjaer SK. Frederiksen K, Munk C, Iftner T. Long-term absolute risk of CIN3 or worse following one positive test or persistence of different individual HPV types J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88
Jensen KE, Munk C, Sparen P, Tryggvadottir L, Liaw KL, Dasbach E, Nygård M, Kjaer SK. Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand. 2011 May;90(5):459-467. doi: 10.1111/j.1600-0412.2010.01066.x. Epub 2011 Feb 5.
Olesen, TB, Jensen KE, Nygård M, Tryggvadottir L, Sparén P, Hansen BT, Liaw K-L, Kjær SK. Young age at first sexual intercourse and subsequent risk-taking behaviours – A population-based study of nearly 65,000 women in four Nordic countries Eur J Public Health 2012 Apr;22(2):220-4. doi: Epub 2011 May 19.
Buttmann N, Nielsen A, Munk C, Liaw KL, Kjaer SK. Sexual risk taking behaviour: prevalence and associated factors. A population-based study of 22 000 Danish men. BMC Public Health. 2011 Oct 5;11(1):764. [Epub ahead of print]
Gheit T, Cornet I, Clifford CM, Iftner T, Munk C, Tommasino M, Kjaer SK Risks for Persistence and Progression by Human Papillomavirus Type 16 variant lineages among a population-based sample of Danish Women. Cancer Epidemiol Biomarkers and Prev 2011; Jul;20(7):1315-21. Epub 2011 Apr 28.
Tuxen M, Nielsen A, Nygaard M, Sparén P, Tryggvadottir L, Hansen BT, Liaw K-L, Kjær SK. Chlamydia, Herpes, Trichomonas and Gonorrhea - Prevalence and risk factors among nearly 70,000 randomly selected women in four Nordic countries. Sex Transm Dis. 2011 Aug;38(8):727-734.
Baandrup L , Munk C , Andersen KK, Junge J, Iftner T, Kjaer SK. HPV16 is Associated with Younger Age in Women with Cervical Intraepithelial Neoplasia Grade 2 and 3. Gynecol Oncol. 2012 Feb;124(2):281-5. Epub 2011 Oct 25.
Rinaldi S, Plummer M, Biessy C, Castellsague X, Overvad K, Krüger Kjær S, Tjonneland AA, Clavel-Chapelon F, Chabbert-Buffet N, Mesrine S, Lukanova A, Kaaks R, Weikert C, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, van Kranen HJ, Peeters PH, Bakken K, Lund E, Torhild Gram I, Rodriguez L, Bosch FX, Sanchez MJ, Dorronsoro M, Navarro C, Barricarte Gurrea A, Kjellberg LD, Dillner J, Manjer J, Butt S, Khaw KT, Wareham NJ, Allen NE, Travis RC, Romieu II, Ferrari P, Riboli E, Franceschi S. Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study. Cancer Epidemiology Biomarkers Prev. 2011 Oct 12. [Epub ahead of print]
Plummer M, Peto J, Franceshi S on behalf of the International Collaboration of Epidemiological Studies of Cervical Cancer. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 2011 Jun 23. doi: 10. 1002/ijc.26250. [Epub ahead of print]
Iftner T, Eberle S, Iftner A, Holz B, Banik N, Quint W, Straube AN. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study J Med Virol. 2010 Nov;82(11):1928-39.
Stoler MH, Vichnin MD, Ferenczy A, Ferris DG, Perez G, Paavonen J, Joura EA, Djursing H, Sigurdsson K, Jefferson L, Alvarez F, Sings HL, Lu S, James MK, Saah A, Haupt RM; FUTURE I, II and III Investigators The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer. 2011 Mar 15;128(6):1354-62. doi: 10.1002/ijc.25470.
Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Majewski S, Muñoz N, Sings HL, Harkins K, Rutkowski MA, Haupt RM, Garner EI; FUTURE I and II Study Group. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. Int J Cancer. 2011 Mar 15;128(6):1344-53. doi: 10.1002/ijc.25723. Epub 2011 Jan 12.
Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, Koutsky LA, Sings HL, Lu S, Haupt RM, Paavonen J; FUTURE I and II Study Group. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect. 2011 Aug;87(5):372-6. Epub 2011 Apr 6.
Haupt RM, Wheeler CM, Brown DR, Garland SM, Ferris DG, Paavonen JA, Lehtinen MO, Steben M, Joura EA, Giacoletti KE, Radley DR, James MK, Saah AJ, Sings HL; FUTURE I and II Investigators. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. Int J Cancer. 2011 Dec 1;129(11):2632-42. doi: 10.1002/ijc.25940. Epub 2011 Apr 13.
Reiser J, Hurst J, Voges M, Krauss P, Münch P, Iftner T, Stubenrauch F High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J Virol. 2011 Nov;85(21):11372-80.
Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer – a Danish study of nearly 50,000 patients with genital warts Journal of Infectious Diseases 2012 May 15;205(10):1544-53. Epub 2012 Mar 15.
Manawapat A, Stubenrauch F, Russ R, Munk C, Kjær SK, Iftner T. Physical state and viral load as predictive biomarkers for persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study. J Sexually Transmitted. Infections 2012 Dec;88(8):627-32. doi: 10.1136/sextrans-2011-050307. Epub 2012 Jul 6.
Nielsen A, Iftner T, Nørgaard M, Munk C, Cohet C, Junge J, Kjaer SK Importance of type-specific low-risk human papillomavirus infection for the risk of abnormal cervical cytology/histology in more than 40,000 Danish women. Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):835-42. Epub 2012 Mar 20.
Ibfelt E, Kjær SK, Johansen C, Høgdall C, Steding-Jessen M, Frederiksen K, Birgitte Frederiksen3, Merete Osler3, Susanne Oksbjerg Dalton Socioeconomic position in relation to stage at diagnosis of cervical cancer and the mediation of comorbidity and smear testing in Danish patients diagnosed 2005-09 Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1949-55.
Jensen KE, Schmiedel S, Frederiksen K, Norrild B, Iftner T, Kruger Kjær S. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1949-55.
Jensen KE, Schmiedel S, Norrild B, Frederiksen K, Iftner T, Kjaer SK. Risk of HSIL in HPV positive. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer. 2012 Nov 20. doi: 10.1038/bjc.2012.513.
Baandrup L, Blomberg M, Dehlendorff, Sand C, Andersen KK, Kjaer SK. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sexually Trans Dis 2012
Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, Gernow A, Ejlersen SF, Munk C, Iftner T, Kjaer SK. HPV prevalence and type distribution in 3603 HIV positive and HIV negative women in the general population of Tanzania: the PROTECT study. Sexually Transmitted Diseases 2012 Mar;39(3):201-208.
Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM; for the FUTURE I and II Study Group Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ. 2012 Mar 27;344:e1401. doi: 10.1136/bmj.e1401
Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, Rodriguez MS, Serradell L, Torcel-Pagnon L, Cortes J; for the CLEOPATRE Spain Study Group. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study. J Med Virol. 2012 Jun;84(6):947-956. doi: 10.1002/jmv.23282.
Roura E, Iftner T, Vidart JA, Krüger Kjaer S, Bosch FX, Muñoz N, Palacios S, San Martin Rodriguez M, Morillo C, Serradell L, Torcel-Pagnon L, Cortes J, Castellsagué X, Study Group CS. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis. 2012 Jun 26;12(1):145.
Kahesa , Kjaer SK, Mwaiselage J, Ngoma T, Tersbol B, Dartell M and Rasch V Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania. BMC Public Health 2012 Dec 7;12(1):1055
Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012 Nov 20;30 Suppl 5:F24-33. Doi
Ruiz AM, Ruiz JE, Gavilanes AV, Eriksson T, Lehtinen M, Pérez G, Sings HL, James MK, Haupt RM; for the FUTURE I and II Study Group Proximity of First Sexual Intercourse to Menarche and Risk of High-Grade Cervical Disease. J Infect Dis. 2012 Dec;206(12):1887-1896. Epub 2012 Oct 12.
Schenker A, Straub E, Iftner T, Stubenrauch F. Cell-type dependent activities of regulatory regions and E2 proteins derived from carcinogenic and non-carcinogenic α-Human Papillomaviruses. J Gen Virol. 2013 Jun;94(Pt 6):1343-50. doi: 10.1099/vir.0.049072-0. Epub 2013 Feb 13.


MERMAID I - -
Jones, C., Khalique, L., Hogdall, E.V., Hogdall, C.K., Jacobs, I., Kruger Kjaer, S., Gayther, S.A. Array Pipeline: A dedicated Laboratory Information Management System and associated software utilities for CGH-microarray manufacture and analysis. Eur J Med Genet 2005 48:472-3 (Project 4)
J. Beesley, S.J. Jordan, A. B. Spurdle, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), J. L. Hopper, H. Song, S.J. Ramus, S. Kruger Kjaer, E. Hogdall, R. A. DiCioccio, A. S. Whittemore, Simon A. Gayther, Paul D.P. Pharoah, P.M. Webb and G. Chenevix-Trench Association between SNPs in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2557-65. (Project 1)
Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Gayther S, Jacobs IJ, Høgdall CK Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer From the Danish "MALOVA" Ovarian Cancer Study. Gynecol Oncol. 2007 106:318-24 (Project 5)
Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Oncol Rep. 2007 Nov;18(5):1051-9.(Project 5)
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, Green AC, Whiteman DC; Australian Ovarian Cancer Study Group, Goodman MT, Lurie G, Carney ME, Modugno F, Ness RB, Edwards RP, Moysich KB, Goode EL, Couch FJ, Cunningham JM, Sellers TA, Wu AH, Pike MC, Iversen ES, Marks JR, Garcia-Closas M, Brinton L, Lissowska J, Peplonska B, Easton DF, Jacobs I, Ponder BA, Schildkraut J, Pearce CL, Chenevix-Trench G, Berchuck A, Pharoah PD; Ovarian Cancer Association Consortium. Tagging Single Nucleotide Polymorphisms In Cell Cycle Control Genes And Susceptibility To Invasive Epithelial Ovarian Cancer Cancer Res 2007 67:3027-3035 (Project 1)
Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, Gayther SA, D P Pharoah P. Tagging Single Nucleotide Polymorphisms In The BRIP Gene And Susceptibility To Breast And Ovarian Cancer. PLoS ONE. 2007 7;2:e268. (Project 1)
Hogdall EV, Christensen L, Kjaer SK, Blaakaer J, Kjaerbye-Thygesen A, Gayther S, Jacobs IJ, Hogdall CK. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study. Gynaecologic Oncology 2007 104:508-515 (Project 5)
Kjærbye-Thygesen A, Huusom LD, Frederiksen K. Kjaer SK. Primary ovarian cancer. A comparison of registrations in the Danish Cancer Registry and in the Pathology Data Bank. Ugeskr Laeger. 2007 Jan 1;169(1):50-4.
Soegaard M, Jensen A, Høgdall E, Christensen L, Høgdall C, Blaakaer J, Kjaer SK. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1160-6
Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nøhr B, Munk C, Kjaer SK. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Eur J Cancer. 2008 Sep;44(14):2003-17. Epub 2008 Jul 26. (related paper)
Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole CL, Berchuck A, Anderson AR, Anderson S, Anton-Culver H, Australian Cancer Study (Ovarian Cancer Group), Australian Ovarian Cancer Study Group,, Beesley J, Blaaker J, Brewster W, Carney ME, Chen X, Chenvix-Trench G, Chang-Claude J, Cunningham JM, DiCioccio RA, Doherty JA, Easton DF, Edlund CK, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Hogdall CK, Hogdall E, Hopkins MP, Jenison EL, Kruger Kjaer S, Lurie G, McGuire V, Menon U, Moysich KB, Ness RB, Pearce CL, Pharoah PDP, Pike MC, Ramus SJ, Rossing MA, Song H, Terada KY, Van Den Berg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Schildkraut JM, on behalf of the Ovarian Cancer Association Consortium. Polymorphism in the IL18 gene and no risk of epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev. 2008 17:3567-3572 (Project 1)
Begum FD, Høgdall CK, Kjaer SK, Blaakaer J, Christensen L, Ryan A, Jacobs IJ, Høgdall EV. Distribution of microsatellite instability in Danish ovarian tumor patients and the prognostic value in ovarian cancer patients Oncol Res. 2008;17(1): 43-9 (Project 5)
Quaye L, Gayther SA, Ramus SJ, DiCioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakær J, Easton DF, Ponder BAJ, Jacobs IJ, Kruger Kjaer S, Whittemore AS, Pearce CL, Pharoah PDP, Song H. The Effects Of Common Genetic Variants In Oncogenes On Ovarian Cancer Survival. Clin. Cancer Res. 2008 14:5833-5839 (Project 1)
Mann A, Hogdall E, Ramus SJ, Dicioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Ponder BA, Kjaer SK, Gayther SA, Thompson DJ, Pharoah PD, Song H. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. Eur J Cancer. 2008 Aug 22. [Epub ahead of print] (Project 1)
Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Jarle Christensen I, Gayther S, Jacobs IJ, Høgdall CK. Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study. Pathology. 2008 Aug;40(5):487-92. (Project 5)
Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst. 2008 Jul 2;100(13):962-6. Epub 2008 Jun 24. (Project 1)
Soegaard M, Kjaer SK, Cox M, Wozniak E, Høgdall E, Høgdall C, Blaakaer J, Jacobs IJ, Gayther SA, Ramus SJ. BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res. 2008 Jun 15;14(12):3761-7. (Project 2
Høgdall V, Christensen L, Høgdall CK, Frederiksen K, Gayther S, Blaakaer J, Jacobs IJ, Kjaer SK. Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas. APMIS. 2008 May;116(5):400-9. (Project 5)
Soegaard M, Jensen A, Frederiksen K, Høgdall E, Høgdall C, Blaakaer J, Kjaer SK. Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer. Cancer Causes Control. 2008 Jun;19(5):469-79. (Project 2)
Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer), Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL; Ovarian Cancer Association Consortium. Consortiu m analysis of 7 candidate SNPs for ovarian cancer Int J Cancer. 2008 Jul 15;123(2):380-8. (Project 1)
Morris JA, Gayther SA, Jacobs IJ, Jones C. A suite of Perl modules for handling microarray data. Bioinformatics. 2008 Apr 15;24(8):1102-3.. (Project 4)
Morris, J., Jacobs, I., Gayther, S.A. and Jones, C. A Perl toolkit for LIMS development. Source Code Biol Med. 2008 Mar 19;3:4. (Project 4)
Pearce CL, Wu AH, Gayther SA, Bale AE; Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, Hartmann LC, Hogdall E, Kjaer SK, Lissowska J, McGuire V, Modugno F, Moysich K, Ness RB, Ramus SJ, Risch HA, Sellers TA, Song H, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore AS, Zheng W, Pharoah PD, Chenevix-Trench G, Pike MC, Schildkraut J, Berchuck A; Ovarian Cancer Association Consortium. Progesterone Receptor Variation and Risk of Invasive Epithelial Ovarian Cancer: Results from the Ovarian Cancer Association Consortium Pooled Analysis. Br J Cancer. 2008 Jan 29;98(2):282-8. (Project 1)
Song H, Hogdall E, Ramus SJ, Dicioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Kjaer SK, Pharoah PD, Gayther SA.. Effects of common germline genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res. 2008 Feb 15;14(4):1090-5. (Project 1)
Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Couch FJ, Wang X, Fridley BL, Gayther SA, Song H, Hogdall E, Kjaer SK, Whittemore A, DiCioccio R, Ramus SJ, Pharaoh PDP, Goode EL. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. B J Cancer 2009 Oct 20;101(8):1461-8. Epub 2009 Sep 8. (Project 1)
Song H, Ramus SJ, Tyrer J, Bolton K, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, Baglietto L, Beckmann MW, Beesley J, Blaakaer J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, Duerst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, Gore ME, De Vivo I, Hillemanns P, Hogdall C, Hogdall E, Iversen ES, Jacobs IJ, Jakubowska A, Li D, Lissowska J, Lubiński J, Lurie G, McGuire V, McLaughlin J, Mędrek K, Moorman PG, Moysich K, Narod S, Phelan C, Pye C, Risch H, Runnebaum IB, Severi G, Southey M, Stram DO, Thiel FC, Terry KL, Tsai Y, Tworoger SS, Van Den Berg DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A, Australian Cancer (Ovarian) Study, The Australian Ovarian Cancer Study Group, The Ovarian Cancer Association Consortium, Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder BAJ, Pearce CL, Ness RB, Menon U, Krüger Kjaer S, Gronwald J, Garcia-Closas M, Fasching PA, Easton DF, Chenevix-Trench G, Berchuck A, Pharoah PDP and Gayther SA. Genome-Wide Association Study Identifies A Novel Ovarian Cancer Susceptibility Locus On 9p22.2 Nat. Genetics 2009 41:996-1000 (Project 1)
Quaye L, Tyrer J, Ramus SJ, Song H, Wozniak E, DiCioccio RA, McGuire V, Høgdall E, Høgdall C, Blaakaer J, Easton DF, Ponder BAJ, Krüger-Kjaer S, Whittemore AS, Gayther SA, Pharoah PDP PDP Association between Common Germline Genetic Variation in 94 Candidate Genes or regions and Risks of Invasive Epithelial Ovarian Cancer PLoS One 2009 Jun 19;4(6):e5983 (Project 1)
Song H, Ramus SJ, Krüger Kjaer S, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Menon U, Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X, the Australian Cancer (Ovarian) Study, The Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, PJ, and Carney ME, Ness RB, Moysich K, Goode EL, Vierkant RA, Cunningham JM, Anderson S, Schildkraut JM, Berchuck A, Iversen ES , Moorman, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Anton-Culver H, Ziogas A, Brewster WR, Ponder BAJ, Easton DF, Gayther SA and Pharoah PDP on behalf of the Ovarian Cancer Association Consortium (OCAC). Association between invasive ovarian cancer and 11 top hits from breast cancer genome-wide association study. Hum Mol Genet. 2009 18:2297-304 (Project 1)
Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, Krüger Kjaer S, Hogdall E, Blaakaer J, Hogdall C, Easton DF, Song H, Pharoah PD, Whittemore AS, McGuire V, Quaye L, Anton-Culver H, Ziogas A, Terry KL, Cramer DW, Hankinson SE, Tworoger SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M; Australian Ovarian Cancer Study Group Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer Cancer Res. 2009 69:2349-57 (Project 1)
Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, Pankratz VS, Song H, Hogdall E, Kruger Kjaer S, Whittemore AS, DiCioccio R, Ramus SJ, Gayther SA, Schildkraut JM, Pharaoh PDP, and Sellers TA Candidate Gene Analysis Using Imputed Genotypes: Cell Cycle Genes and Ovarian Cancer Risk Cancer Epidemiol Biomarkers Prev. 2009 18(3):935-44. (Project 1)
Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, Dicioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JC, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PD, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group. A SNP in CYP3A4 is Associated with Genetic Susceptibility to Ovarian Cancer Br J Cancer 2009100(2):412-20 (Project 1)
Søgaard M, Frederiksen K, Jensen A, Hogdall E, Hogdall C, Blaakær J, Ramus, S, Gayther S. Risk of ovarian cancer in relation to cancer history in first degree relatives. Acta Obstet Gynecol Scand 2009 88:449-56 (Project 2)
Høgdall E, Ringsholt M, Høgdall CK, IJ Christense, Johansen JS, Kjaer SK, Blaakaer J, Ostenfeld-Møller L, Price PA, Christensen LH. YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer. 2009 Jan; 9; 9:8 (Project 5)
Begum FD, Høgdall E, Kjaer SK, Blaakaer J, Christensen IJ, Christensen L, Høgdall C. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors. Gynecol Oncol 2009 May; 113 (2):221-7. (Project 5
Dafou D, Ramus SJ, Choi K, Grun B, Trott DA, Newbold RF, Jacobs IJ, Jones C, Gayther SA. Neoplastic Suppression in Epithelial Ovarian Cancer Cells Lines by Microcell-mediated transfer of chromosomes 6 and 18. Int J Cancer 2009 124:1037-44 (Project 3 and 5)
Quaye L, Song, H, Ramus SJ, Pearce CL, Gentry-Maharaj A, Hogdall E, DiCioccio RA, Wu A, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BAJ, Whittemore AS, Kruger Kjaer S, Menon U, Pharoah PDP, Gayther SA. Tagging Single Nucleotide Polymorphisms In Candidate Oncogenes And Susceptibility To Ovarian Cancer. Br J Cancer 2009 100:993-1001 (Project 1)
Petri AL, Kjaer SK, Christensen IJ, Blaakaer J, Hogdall E, Jeppesen U, Mosgaard BJ, Pagel JD, Stilling L, Thranov I, Hogdall C Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database. Acta Obstet Gynecol Scand. 2009;88(5):536-42.
Petri AL, Simonsen AH, Yip TT, Hogdall E, Fung ET, Lundvall L, Hogdall C.. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology. Acta Obstet Gynecol Scand. 2009;88(1):18-26.
Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ. 2009 Feb 5;338:b249.
West-Nørager M, Bro R, Marini F, Høgdall EV, Høgdall CK, Nedergaard L, Heegaard NH. Feasibility of serodiagnosis of ovarian cancer by mass spectrometry. Anal Chem. 2009 Mar 1;81(5):1907-13.
Jochumsen KM, Tan Q, Høgdall EV, Høgdall C, Kjaer SK, Blaakaer J, Kruse TA, Mogensen O Gene expression profiles as prognostic markers in women with ovarian cancer. Int J Gynecol Cancer. 2009 Oct;19(7):1205-13.
Sparholt MH, Høgdall E, Høgdall CK Tumour markers in epithelial ovarian cancer] Ugeskr Laeger. 2009 Nov 23;171(48):3505-9.
Risum S, Høgdall E, Engelholm SA, Fung E, Lomas L, Yip C, Petri AL, Nedergaard L, Lundvall L, Høgdall C. A proteomics panel for predicting optimal primary cytoreduction in stage III/IV ovarian cancer. Int J Gynecol Cancer. 2009 Dec;19(9):1535-8.
Petri AL, Simonsen A, Høgdall E, Christensen IJ, Krüger Kjaer S, Yip C, Risum S, Pedersen AT, Hartwell D, Fung ET, Høgdall C. Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis. Proteomics Clin. Appl. 2010, 4, 304–314
Begum FD, Høgdall EV, Jarle IC, Kjaer SK, Blaakær J, Christensen L, Høgdall C Serum tetranectin as a preoperative indicator for postoperative complications in Danish ovarian cancer patients Gynecol Oncol. 2010 Jun;117(3):446-50
Pearce CL, Templeman C, Rossing MA, Lee A, Near A, Australian Cancer Study (Ovarian Cancer) , Australian Ovarian Cancer Study Group, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Wang-Gohrke S, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K,. Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Ziogas A, Brewster W, Anton-Culver H, Gentry Maharaj A, Ramus SJ, Anderson R, Brueggmann D, Fasching PA, Gayther SA, Huntsman D, Menon U, Nagle5 CM, Ness R, PikeMC, Risch H, Webb PM, Wu AH, Berchuck A on behalf of the Ovarian Cancer Association Consortium. (Ingen titel på emne) JNCI (submitted Nov 20, 2010) (Project 1)
Amankwah EK, Wang Q, Schildkraut JM, Tsai Y, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Australian Ovarian Cancer Study Group, Dale LC, Lambrechts D, Amant F, Despierre E, Vergote I, Gayther SA, Gentry-Maharaj A, Menon U, Chang-Claude J, Wang-Gohrke S, Anton-Culver H, Ziogas A, Doerk T, Duerst M, Antonenkova N, Bogdanova N,15, Brown R, Flanagan JM, Kaye SB, Paul J, Bützow R, Nevanlinna H, Campbell I, Eccles DM, Karlan BY, Gross J, Walsh C, Pharoah P, Song H, Kjær SK, Høgdall E, Høgdall C, Lundvall L, Nedergaard L, Kiemeney L, Massuger L, van Altena AM, Vermeulen S, Le ND, Brooks-Wilson A, Cook LS, Phelan CM, Cunningham JM, Vachon CM, Vierkant RA, Iversen ES, Berchuck A, Goode EL, Sellers TA and Kelemen LE on behalf of the Ovarian Cancer Association Consortium. Pearce CL, Ramus SJ, Jacobs IJ, Gayther SA. Polymorphisms in stromal genes decorin and lumican and susceptibility to serous ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One2010 (submitted Nov. 2010) (Project 1)
Ramus, S, Quaye L, Wosniak E, Høgdall E, Høgdall C, Blaakær J, Kruger Kjaer S, Jacobs I, Gayther S. Evaluating Whole Genome Amplification Methods and Multiplex SNP Genotyping Platforms for Genetic Association Studies. PlosONE 2010 (submitted April) (Project 1)
Dafou D, Grun B, Sinclair J, Lawrenson K, Benjamin EC, Hogdall E, Kruger-Kjaer S, Christensen L, Sowter HM, Al-Attar A, Edmondson R, Darby S, Berchuck A, Laird PW, Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia. 2010 Jul;12(7):579-89. (Project 1)
Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM; Australian Cancer Study (Ovarian Cancer) Study Group, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Cramer DW, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Fredericksen ZS, Fridley BL, Gates MA, Gayther SA, Gentry-Maharaj A, Høgdall E, Kjaer SK, Lurie G, Menon U, Moorman PG, Moysich K, Ness RB, Palmieri RT, Pearce CL, Pharoah PD, Ramus SJ, Song H, Stram DO, Tworoger SS, Van Den Berg D, Vierkant RA, Wang-Gohrke S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1822-30. Epub 2010 Jun 22. (Project 1)
Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Høgdall CK Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study. APMIS. 2010 Aug;118(8):557-64. (Project 5)
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM; the Australian Cancer Study (Ovarian Cancer) (ACS).,; the Australian Ovarian Cancer Study Group (AOCS), Kjær SK, Hogdall E, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Schildkraut JM, Moorman PG, Palmieri RT, Ness RB, Moysich K, Cramer DW, Terry KL, Vitonis AF, Pike MC, Berchuck A, Pearce CL; on behalf of the Ovarian Cancer Association Consortium. Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertil Steril. 2010 Aug 16. [Epub ahead of print] (project 1)
Johnatty SE, Beesley J, Chen X, Duffy D, Spurdle AB, DeFazio A, Gava N, Webb PM, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Rossing MA, Chang Claude J, Goodman M, Ness R, Cramer D, Hankinson S, Garcia-Closas M, Pharoah P, Whitemore A, Pearce CL, Gayther SA, Anton-Culver H, Hogdal E, Berchuck A, Ramus SJ, Menon U, Gentry-Maharaj A, Rider DN, Goode EL, Haviv I, Chenevix-Trench G on behalf of the Ovarian Cancer Association Consortium. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility “hot-spot”. PLoS Genet. 2010 Jul 8;6(7):e1001016 (Project 1)
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Le ND, Cook LS, Kelemen LE, Brook-Wilson A, Massuger LF, Kiemeney LA, Aben KK, van Altena AM, Houlston R, Tomlinson I, Palmieri RT, Moorman PG, Schildkraut J, Iversen ES, Phelan C, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Kruger-Kjaer S, Blaeker J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Butzow R, Nevanlinna H, Leminen A, Bogdanova N, Antonenkova N, Doerk T, Hillemanns P, Dürst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen C, Rafnar T, Besenbacher S, Sulem P, Stefansson K, Birrer MJ, Terry KL, Hernandez D, Cramer DW, Vergote I, Amant F, Lambrechts D, Despierre, Ekici AB, Chen X; the Australian Ovarian Cancer Study Group; the Australian Cancer Study (Ovarian Cancer); on behalf of the Ovarian Cancer Association Consortium, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas M, Sellers T, Easton DF, Berchuck A, Chenevix-Trench G, Pharoah PD, Gayther SA. E, Fasching PA, Beckmann MW, Thiel FC, Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010 42, 880-884 (Project 1)
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; The Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; The Australian Cancer Study (Ovarian Cancer); The Australian Ovarian Cancer Study Group; the Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Dürst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PD. AB, Thiel FC, Beckmann MW, Yang H, A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 Nat Genet. 2010 Nat Genet. 2010 42, 874-879 (Project 1)
Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, Wozniak E, Sher T, Jacobs IJ, Tyrer J, Schildkraut JM, Moorman PG, Iversen ES, Jakubowska A, Medrek K, Lubiński J, Ness RB, Moysich KB, Lurie G, Wilkens LR, Carney ME, Wang-Gohrke S, Doherty JA, Rossing MA, Beckmann MW, Thiel FC, Ekici AB, Chen X, Beesley J, Gronwald J, Fasching PA, Chang-Claude J, Goodman MT, Chenevix-Trench G, Berchuck A, Pearce CL, Whittemore AS, Menon U, Pharoah PD, Gayther SA, Ramus SJ; The Australian Ovarian Cancer Study Group/Australian Cancer Study (Ovarian Cancer); on behalf of the Ovarian Cancer Association Consortium. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer Int J Cancer. 2010 Jul 15. [Epub ahead of print] (Project 1)
Phelan CM, Tsai1 YY, Goode EL, Cunningham JM, Fredericksen ZS, Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group, Beesley J, Chen X, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Kropp S, Green AC, Hartmann LC, Couch F, Vierkant RA, Lissowska J, Carney ME, Lurie G, Wilkens LR, Modugno F, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Webb PM, Whiteman DC, Whittemore A, DiCioccio RA, McGuire V, Holt SK, Chen C, Doherty JA, Rossing MA, Anton-Culver H, Ziogas A, Hogdall C, Hogdall E, Krüger Kjaer S, Blaakaer J, Ramus SJ, Gentry-Maharaj A, Menon A, Pharoah PDP, Iversen ES, Marks JR, Pike MC, Gayther SA, Goodman MT, Schildkraut JM, Chenevix-Trench G, Berchuck A and Sellers TA on behalf of the Ovarian Cancer Association Consortium (OCAC). Polymorphisms in the GALNT1 Gene and Epithelial Ovarian Cancer Risks in Non-Hispanic White Women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):600-4. (Project 1)
Begum FD, Høgdall E, Christensen IJ, Kjaer SK, Blaakaer J, Christensen L, Høgdall C. Serum tetranectin is a significant prognostic marker in ovarian cancer patients. Acta Obstet Gynecol Scand 2010 Feb;89(2):190 (Project 5)
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Hogdall E, Kruger Kjaer S, Goode EL, Cunningham JM, Berchuck A, Moorman PG, Schildkraut JM, Cramer DW, Terry KL, Garcia-Closas M, Lissowska J, Song H, Pharoah PDP, McGuire V, Whittemore AS, Gayther SA, Ramus SJ, Anton-Culver H, The Australian Ovarian Cancer Study Group, The Australian Cancer Study (Ovarian Cancer), Leigh Pearce CL on behalf of the Ovarian Cancer Association Consortium (OCAC). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers and Prevention 2010 Jan;19(1):245-50.. (Project 1)
Hogdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Norgaard-Pedersen B, Hogdall CK. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Cancer. 2003;98:66-73.
Hogdall EV, Kjaer SK, Glud E, Christensen L, Blaakaer J, Vuust J, Bock JE, Norgaard-Pedersen B, Hogdall CK. Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study. Anticancer Res. 2003;23:3397-404.
Hogdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Hogdall CK. High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. Oncol Rep. 2003;10:1535-8.
Hogdall EV, Hogdall CK, Blaakaer j, Christensen L, Bock JE, Vuust J, Glud E, Kjaer SK. K-ras alterations in Danish ovarian tumour patients. From the Danish “Malova” Ovarian Cancer study. Gynecol Oncol. 2003;89:31-6.
Dehn H, Hogdall EV, Johansen JS, Jorgensen M, Price PA, Engelholm SA, Hogdall CK. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstet Gynecol Scand. 2003;82:287-93.
Brinton LA, Kjær SK, Thomsen BL, Sharif H, Graubard B, Olsen JH, Bock JE Childhood tumor risk following treatment with ovarian stimulating drugs Fertility and Sterility. 2004;81:1083-91.
Holten-Andersen MN, Schrohl AS, Brunner N, Nielsen HJ, Hogdall CK, Hogdall EV. Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay. Int J Biol Markers. 2003;18:170-6.
Gronlund B, Hansen HH, Hogdall C, Hogdall EV, Engelholm SA. Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma? Br J Cancer. 2004;90:377-82.
Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, Bock JE, Blaakaer J. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med. 2004;164:2253-9.
Hogdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Hogdall CK. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma. Cancer. 2004;100:2387-95.
Gronlund B, Hogdall C, Hilden J, Engelholm SA, Hogdall EV, Hansen HH. Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma? J. Clin Oncol. 2004;22:4051-8.
Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Høgdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S. STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:1589-94.
Begum FD, Hogdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, Glud E, Hoyer-Hansen G, Ring-Larsen H, Hogdall EV. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients. Anticancer Res. 2004;24:1981-5.
Pastrana DV, Buck CB, Pang Y-YS, Thompson CD, Castle PE, Kjær SK, Lowy DR, Schiller JT Reactivity of Human Sera in Sensitive High Throughput Pseudovirus Based Neutralization Assays for HPV16 and HPV18 Virology. 2004;321: 205-16.
Kjær SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A population-based follow-up study of more than 65 000 sterilized women Int J Epidemiol 2004; 33:596-602.
Kirschner B, Simonsen K, Junge J, Kjær SK Livmoderhalskræft og human papillomavirus. Nye perspektiver inden for screening af livmoderhalskræft Månedskr Prakt Lægegern. 2005;83: 923-8.
Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Høgdall E, Høgdall C, Stratton J, Whittenmore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, Pharoah PD. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk Int J Cancer. 2005 May 27;
Bøjesen SE, Kjær SK, Høgdall EV, Thomsen BL, Høgdall CK, Blåkær J, Tybjær-Hansen A, Nordestgaard BG Increased risk of ovarian Cancer in integrin beta3 Leu33Pro homozygotes Endocr Relat Cancer. 2005;12: 945-52.
Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjær SK, Graubard BI, Olsen JH, Mellemkjaer L Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors Cancer Epidemiol, Biomarkers and Prevention. 2005;14:2929-35.
Kjærbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK Trends in the Incidence and Mortality of Ovarian Cancer in Denmark 1978-2002. Comparison with other Nordic countries ACTA. 2005;84:1006-12.
Kjaer SK, Munk C, WintherJF, Jørgensen HO, Meijer C, van den Brule A Acquisition and persistence of HPV infection in younger men. A prospective follow-up study among Danish soldiers Cancer Epidemiol, Biomarkers and Prevention. 2005;14:1528-33.
West-Nielsen M, Høgdall EV, Marchiori E, Høgdall CK, Sshou C, Heegaard NH Sample handling for mass spectrometric proteomic investigations of human sera Anal Chem. 2005;77: 5114-23.
International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 Int J Cancer. 2006 Mar 28; [Epub ahead of print]
Kyndi M, Frederiksen K, Kjær SK Cervical cancer incidence in Denmark over six decades (1943-2002). Acta Obstet Gynecol Scand. 2006;85:106-11.
Moscicki AB, Schiffman M, Kjaer SK, Villa, LL: Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006 Aug 21;24 Suppl 3:S42-51. Epub 2006 Jun 23.
Kjaer S, Høgdall E, Frederiksen K, Munk C, Van den Brule A, Svare E, Meijer C, Lorincz A, Iftner T. The absolute risk of cervical abnormalities in high-risk HPV positive, cytologically negative women over a 10 year period. Cancer Res. 2006 Nov 1;66(21):10630-6. Epub 2006 Oct 23.
Kjær SK, Olesen F, Toftager-Larsen K, Sand C, Strauss GI, Hoffmann TU, Ottesen BS The first HPV vaccine is now available Ugeskr Laeger. 2006;168:3827-8.
Kjær SK Vaccine against human papillomavirus Ugeskr Læg 2006;12:1218.
Tolstrup JS, Munk C, Thomsen B, Svare E, van den Brule AJC, Grønbæk M, Meijer C, Kjær SK The role of smoking and alcohol intake in the development of HSIL among high-risk HPV positive women Acta Obstet Gynecol Scand. 2006;85:1114-9.
Soegaard M, Kjaer SK, Gayther S. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand. 2006:93-105.
Kjærbye-Thygesen A, Frederiksen K, Høgdall EV, Glud E, Christensen L, Høgdall CK, Blaakjaer J, Kjaer SK Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:798-803.
Kjærbye-Thygesen A, Frederiksen K, Høgdall EV, Høgdall CK, Blaakjaer J, Kjaer SK Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variables. Eur J Gyn Oncol 2006;XXVII:467-472
Høgdall EV, Kjær SK, Blaakær J, Christensen L, Glud E, Vuust J, Høgdall C P53 mutations in tissue from Danish ovarian cancer patients: from the Danish MALOVA ovarian cancer study Gynecol. Oncol. 2006;100:76-82.
Petri AL, Høgdall E, Christensen IJ, Kjær SK, Blåkær J, Høgdall C Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer Apmis. 2006;114: 359-63.
Song H, Ramus SJ, Quaye L, Dicioccio RA, Tyrer J, Lomas E, Shadford D, Høgdall E, McGuire V, Whittemore AS, Easton DF, Ponder BA, Kjær SK, Pharoah PD, Gayther SA. Common variants in mismatch repair genes and risk of invasive ovarian cancer Carcinogenesis 2006 Jun 13:
Huusom LD, Frederiksen K, Høgdall EV, Glud E, Christensen L, Høgdall C, Blåkær J, Kjær SK. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control. 2006;17: 821-9.
Begum FD, Høgdall EV, Riisbro R, Christensen IJ, Engelholm SA, Jørgensen M, Pedersen BN, Høgdall CK. Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC) APMIS. 2006;114: 675-81.
Grønlund b, Høgdall EV, Christensen IJ, Johansen JS, Nørgård-Pedersen B, Engelholm SA, Høgdall C Pre-treatment prediction of chemorestistance in second-line chemotherapy of ovarian cancer: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA125) Int J Biol Markers. 2006;21:141-8.
Høgdall E, Christensen L, Kjær SK, Blaakær J, Kjærbye-Thygesen A, Gayther S, Jacobs IJ, Høgdall C. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumour patients. Gynecol Oncol 2006
Song H, Ramus SJ, Shadforth D, Quaye L, Kru¨ger SK, Dicioccio RA, Dunning AM, Hogdall e, Hogdall C, Whittemore A, McGuire V, Lesueur F, Easton DF, Jacobs I, Ponder BA, Gayther S, Pharoah PD. Common variants in RB1Gene and risk of invasive ovarian cancer Cancer Research. 2006;66:10220-6.
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittermore A, Quaye L,Tyre J, Shadforth D, Hogdall E, Hogdall C, Blaakaer J, DiCioccio R, McGuire V, Webb V, Beesley J, Green AD, Whiteman DC, The Australian Cancer Study (Ovarian Cancer), Goodman MT, Lurie G, Car Tagging Single Nucleotide Polymorphisms In Cell Cycle Control Genes And Susceptibility To Invasive Epithelial Ovarian Cancer. Cancer Research
Buss L, Tolstrup J, Munk C, Bergholt T , Ottesen B, Grønbæk M, Kjaer SK Spontaneous abortion – A prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants Acta Obstet Gynecol Scand. 2006;85:467-75.
Mikkel West-Nørager, Christian Dahl Kelstrup, Christian Schou, Estrid V. Høgdall, Claus K. Høgdall, Niels H. H. Heegaard Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics Journal of chromatography B
Müller LL, Munk C, Thomsen BL, Frederiksen K, Kjaer SK The influence of parity and smoking in the social environment on tobacco consumption among 3672 daily smoking women in Denmark European Addiction Research 2006
Jacobsen R, Jacobsen R, Moller H, Thoresen SO, Pukkala E, Kjaer SK, Johansen C Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark Int J Androl. 2006;29:199-204.
Mellemkjær L, Hasle H, Gridley G, Johansen C, Kjær SK, Olsen JH Risk of cancer in children with the diagnosis immaturity at birth. Paediatr Perinat Epidemiol. 2006;20:231-7.
Kjærbye-Thygesen A, Kjaer SK, Frederiksen K, Høgdall EV, Høgdall CK, Christensen L, Blaakjaer J Prognostic impact of preoperative endogenous hormone status in postmenopausal women diagnosed with epithelial ovarian cancer. Focusing on Inhibin A, Estradiol and Androgens Endocr Relat Cancer
Marie Søgaard, Allan Jensen, estrid Högdall, Lise Christensen, Claus Högdall, Jan Blaakær, Susanne K. Kjaer Different risk factor profiles for mucinous and non-mucinous ovarian cancer. Results from the danish MALOVA study. In preparation.
Huusom LD, Kjærbye-Thygesen A, Frederiksen K, Kjaer SK Registration of ovarian borderline tumours in Denmark 1978-79 In preparation.
Kjærbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK Primær ovariecancer. En sammenligning af registreringer i Cancerregisteret og Patologidatabanken. Ugeskr Laeger